ArticleCancers2018
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer.
Alexander Ring et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled itcites it
ArticleCancers2018
Alexander Ring et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.